Autor:
Díaz-Jiménez, D.
Núñez, L.
De La Fuente, M.
Dubois-Camacho, K.
Sepúlveda, H.
Montecino, M.
Torres-Riquelme, A.
García-González, P.
Chnaiderman, J.
Vossenkamper, A.
MacDonald, T.T.
Simian, D.
González, M.
Cidlowski, J.A.
Quera, R.
Hermoso, M.A.
The ST2/IL33 signalling pathway has been associated with ulcerative colitis (UC). ST2, encoded by the IL1RL1 gene, is expressed as both a membrane-anchored receptor (ST2L) activated by IL33 and as a soluble receptor (sST2) with anti-inflammatory properties. In UC patients, sST2 is further increas...
Enlace original:
http://repositorio.unab.cl/xmlui/handle/ria/5239
Díaz-Jiménez, D.
,
Núñez, L.
,
De La Fuente, M.
,
Dubois-Camacho, K.
,
Sepúlveda, H.
,
Montecino, M.
,
Torres-Riquelme, A.
,
García-González, P.
,
Chnaiderman, J.
,
Vossenkamper, A.
,
MacDonald, T.T.
,
Simian, D.
,
González, M.
,
Cidlowski, J.A.
,
Quera, R.
,
Hermoso, M.A.
,
[A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitis]
,
A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitis
